MedTrace Logo

Treatment of Anemia With Intravenous Iron in Patients Listed for Orthotopic Liver Transplantation

NCT04475887 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-07-28

No results posted yet for this study

Summary

The aim of this study is to investigate whether therapy with intravenous iron carboxymaltose in patients with iron deficiency anemia (IDA) listed for orthotopic liver transplantation (OLT) increases hemoglobin concentrations and reduces intraoperative transfusion of packed red blood cells (PRBCs). The investigators hypothesize that therapy with intravenous iron will increase hemoglobin concentrations and reduce intraoperative transfusion of PRBCs in patients with IDA listed for OLT.

Conditions

  • Liver Transplantation
  • Blood Loss

Interventions

DRUG

Iron Carboxymaltose

see above

DRUG

Placebo

see above

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Georg P Gyoeri, MD · Department of Surgery

  • David M Baron, MD · Department of Anaesthesiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-23
Primary Completion
2022-12-31
Completion
2023-05-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04475887 on ClinicalTrials.gov